Results
In-person events
Out-of-Office Live
Speaker:
Katie Murray, DO, MS, FACS
Black and Blue, 1470 Western Ave, Albany, NY 12203
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Out-of-Office Live
Speaker:
Lambros Stamatakis, MD
Cedar Creek Grille, 2101 Richmond Road, Beachwood, OH 44122
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Out-of-Office Live
Speaker:
Ravi Chauhan, MD
Forbes Mill Steakhouse, 200 Sycamore Valley Rd W, Danville, CA 94526
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Online events
Virtual (Fully Remote)
Speaker:
Lawrence Karsh, MD, FACS, CPI
Location:
Arkansas Urology, 1300 Centerview Drive, Little Rock, AR 72211
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Virtual (Fully Remote)
Speaker:
Rian Dickstein, MD,FACS
Location:
Urology San Antonio, P.A.-Kimpton -San Antonio, 431 South Alamo Street, San Antonio, TX 78205
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Virtual (Fully Remote)
Speaker:
Gautam Jayram, MD
Location:
Online
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.